Foxo Technologies Inc. 的全资子公司 Vector Biosource, Inc. 已签署最终协议，从 Grifols Bio Supplies, Inc. 手中收购其位于四处的血液采集中心。此举标志着该公司在生物资源领域的战略布局迈出实质性一步。
Foxo Technologies Inc. 的全资子公司 Vector Biosource, Inc. 已签署最终协议，从 Grifols Bio Supplies, Inc. 手中收购其位于四处的血液采集中心。此举标志着该公司在生物资源领域的战略布局迈出实质性一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.